Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Rapid Communications in Mass Spectrometry : RCM|August 27, 2014
Mechanism of error caused by isotope-labeled internal standard: accurate method for simultaneous measurement of vitamin D and pre-vitamin D by liquid chromatography/tandem mass spectrometryMin Huang, Amy B Cadwallader, Rebecca HeltsleyJournal of Analytical Toxicology|October 30, 2018
Presence of Parent Cocaine in the Absence of Benzoylecgonine in UrineBrandi L Puet, Kate Claussen, Cheryl Hild, et al.Journal of Addiction Medicine|December 4, 2024
Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without XylazineRyan Alexander, Chinelo Agwuncha, Christopher Wilson, et al.Journal of Addiction Medicine|August 14, 2023
Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient SamplesAndrew C Holt, David M Schwope, Kathy Le, et al.Journal of Analytical Toxicology|November 15, 2011
Screening indicators of dehydroepiandosterone, androstenedione, and dihydrotestosterone use: a literature reviewMelinda K Shelby, Dennis J Crouch, David L Black, et al.BMC Primary Care|April 15, 2023
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic diseaseJohn W Peabody, Divya Ganesan, Czarlota Valdenor, et al.Pharmacotherapy|February 19, 2021
Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill childrenSin Yin Lim, Jamie L Miller, Emilie Henry, et al.International Journal of Clinical Practice|August 22, 2022
Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug-Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care PhysiciansCzarlota Valdenor, Divya Ganesan, David Paculdo, et al.Journal of Analytical Toxicology|July 12, 2011
Urine drug testing of chronic pain patients. IV. prevalence of gabapentin and pregabalinRebecca Heltsley, Anne Depriest, David L Black, et al.Journal of Analytical Toxicology|September 14, 2014
Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patientsDavid M Schwope, Anne DePriest, David L Black, et al.Pageof 3